Free Trial

OnKure Therapeutics (OKUR) Insider Trading & Ownership

OnKure Therapeutics logo
$3.48 +0.04 (+1.02%)
As of 11:09 AM Eastern
This is a fair market value price provided by Massive. Learn more.

OnKure Therapeutics (NASDAQ:OKUR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$3.41M
Get OKUR Insider Trade Alerts

Want to know when executives and insiders are buying or selling OnKure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OKUR Insider Buying and Selling by Quarter

OnKure Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/23/2026
Jason A Leverone
CFO
Sell301$4.16$1,252.16  
3/23/2026
Nicholas A Saccomano
CEO
Sell86$4.16$357.76  
12/22/2025
Jason A Leverone
CFO
Sell302$2.97$896.94  
12/22/2025
Nicholas A Saccomano
CEO
Sell87$2.97$258.39  
9/22/2025
Jason A Leverone
CFO
Sell303$2.62$793.86  
9/22/2025
Nicholas A Saccomano
CEO
Sell88$2.62$230.56  
6/23/2025
Jason A Leverone
CFO
Sell303$2.38$721.14  
6/23/2025
Nicholas A Saccomano
CEO
Sell88$2.38$209.44  
5/15/2025
Cormorant Asset Management, Lp
Major Shareholder
Sell1,813,439$1.85$3,354,862.15  
5/12/2025
Cormorant Asset Management, Lp
Major Shareholder
Sell24,300$1.99$48,357.00  
(Data available from 1/1/2013 forward)

OKUR Insider Trading Activity - Frequently Asked Questions

The list of insiders at OnKure Therapeutics includes Cormorant Asset Management, Lp, Jason A Leverone, and Nicholas A Saccomano. Learn more on insiders at OKUR.

17.90% of OnKure Therapeutics stock is owned by insiders. Learn more on OKUR's insider holdings.

The following insiders have sold OKUR shares in the last 24 months: Cormorant Asset Management, Lp ($3,403,219.15), Jason A Leverone ($12,843.32), and Nicholas A Saccomano ($3,626.01).

Insiders have sold a total of 1,843,293 OnKure Therapeutics shares in the last 24 months for a total of $3,419,688.48 sold.



This page (NASDAQ:OKUR) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners